|
|
| |
 |
Vesicular stomatitis virus-based Ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates
From PLoS Pathog, published online Nov 28
|
|
|
Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda
From PLoS Pathog, published online Nov 21
|
|
|
Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin
From PLoS ONE, published online Nov 14
|
|
|
The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007
From Int J Infect Dis, published online Nov 5
|
|
|
Crimean-Congo hemorrhagic fever: does it involve the heart?
From Int J Infect Dis, published online Nov 4
|
|
|
Adverse event reports following yellow fever vaccination
|
|
|
Spatial and temporal clustering of dengue virus transmission in Thai villages
From PLoS Med, published online Nov 4
|
|
|
Real-time reverse-transcription loop-mediated isothermal amplification for rapid detection of Rift Valley fever virus
From Nov J Clin Microbiol
|
|
|
A case of nosocomial transmission of Crimean-Congo hemorrhagic fever from patient to patient
From Int J Infect Dis, published online Oct 24
|
|
|
Argentine hemorrhagic fever diagnostic test based on recombinant Junin virus N protein
From Dec J Med Virol, published online Oct 21
|
|
|
Multiple virus lineages sharing recent common ancestry were associated with a large Rift Valley fever outbreak among livestock in Kenya during 2006-2007
|
|
|
Analysis of yellow fever vaccination practice in England
From J Travel Med, published online Oct 2
|
|
|
Dengue hemorrhagic fever transmitted by blood transfusion
Letter from Oct 2 N Engl J Med
|
|
|
Recent shift in age pattern of dengue hemorrhagic fever, Brazil
Letter from Emerg Infect Dis, published online Sep 25
|
|
|
Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates
|
|
|
Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus
From PLoS Pathog, published online Aug 29
|
|
|
Identification of a broad-spectrum arenavirus entry inhibitor
From J Virol, published online Aug 20
|
|
|
Pathogenesis of XJ and Romero strains of Junin virus in two strains of guinea pigs
From Aug Am J Trop Med Hyg
|
|
|
Conservation and variability of dengue virus proteins: implications for vaccine design
From PLoS Negl Trop Dis, published online Aug 13
|
|
|
Different mechanisms of cell entry by human-pathogenic Old and New World arenaviruses
|
|
|
Imported dengue hemorrhagic fever, Europe
Letter from Emerg Infect Dis, published online Jul 28
|
|
|
Potential vectors of Rift Valley fever in the Mediterranean region
From Vector-Borne Zoonotic Dis, published online Jul
|
|
|
Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya
From Emerg Infect Dis, published online Jul 23
|
|
|
Relationship between transmission intensity and incidence of dengue hemorrhagic fever in Thailand
From PLoS Negl Trop Dis, published online Jul 16
|
|
|
The enigma of yellow fever in East Africa
From Rev Med Virol, published online Jul 10
|
|
|
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
|
|
|
Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses
|
|
|
Case of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes
From J Infect Dis, published online Jul 3
|
|
|
Yellow fever vaccines and international travelers
From Jul Expert Rev Vaccines
|
|
|
A DNA vaccine for the prevention of Ebola virus infection
From Jun Curr Opin Mol Ther
|
|
|
Managing potential laboratory exposure to Ebola virus by using a patient biocontainment care unit
From Jun Emerg Infect Dis
|
|
|
Pressure-activated yellow fever 17DD virus: implications for vaccine development
|
|
|
Yellow fever-associated viscerotropic disease in Barcelona, Spain
From May-Jun J Travel Med
|
|
|
VHF: Current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, treatment, and prophylaxis
CIDRAP-authored overview updated May 22 with new research
|
|
|
Lassa Fever
|
|
